| 我国医药产业创新药物研发面临的问题及对策探讨 |
| |
| 引用本文： | 刘昌孝. 我国医药产业创新药物研发面临的问题及对策探讨[J]. 中国药房, 2012, 0(22): 2017-2020 |
| |
| 作者姓名： | 刘昌孝 |
| |
| 作者单位： | 天津药物研究院释药技术与药代动力学国家重点实验室 |
| |
| 摘 要： | 目的:为推动我国医药产业创新药物研发提供参考。方法:在研究我国创新药物研发现状的基础上,分析创新药物研发所面临的问题。结果与结论:我国创新药物研发面临研发资金投入不足、研发主题错位、知识产权保护不力、机制落后等问题。建议加大研发资金投入、促使企业成为研发主体、完善知识产权保护、优化相关机制。相信随着我国医药产业结构的调整,行业规范日趋合理,市场运行机制日趋完善,一定能够实现从原料药和仿制药大国到创新药大国的跨越。
|
| 关 键 词： | 医药产业 创新药物 研发 问题 对策 |
Discussion on Problems of Innovative Drug R&D Faced by Pharmaceutical Industry and Countermeasures in China |
| |
| LIU Chang-xiao. Discussion on Problems of Innovative Drug R&D Faced by Pharmaceutical Industry and Countermeasures in China[J]. China Pharmacy, 2012, 0(22): 2017-2020 |
| |
| Authors: | LIU Chang-xiao |
| |
| Affiliation: | LIU Chang-xiao(State Key Laboratory of Drug Release Technology and Pharmacokinetics,Tianjin Institute for Materia Medica,Tianjin 300193,China) |
| |
| Abstract: | OBJECTIVE:To provide reference for the promotion of innovative drug R&D in pharmaceutical industry in China.METHODS:Based on the status quo of innovative drug R&D in China,the problems of innovative drug R&D were analyzed.RESULTS&CONCLUSION:The problems of innovative drug R&D are inadequate fund,R&D subject misplacement,insufficient intellectual property protection,behindhand mechanism,etc.It is suggested to expand input,promote enterprise to be R&D subject,perfect intellectual property protection,optimize related mechanism.The crossover from raw material drug and global generic-drugs great power to innovative drug great power could be realized by adjusting pharmaceutical industrial structure,standardizing industry norms,perfecting operation mechanism. |
| |
| Keywords: | Pharmaceutical industry Innovative drug R&D Problems Countermeasures |
| 本文献已被 CNKI 维普 等数据库收录！ |
|
